Brain magnetic stimulation(DMS)attenuates Alzheimer's disease(AD)-like pathology and improves c

来源 :The 6th FAONS Congress and 11th Biennial Conference of CNS(第 | 被引量 : 0次 | 上传用户:qutong19921107
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective Alzheimers disease(AD)is characterized by the progressive decline of cognitive function among the elderly.
其他文献
Abnormal α-synuclein(α-syn)expression and aggregation have been implicated in the pathogenesis of Parkinsons disease(PD),dementia with Lewy bodies(DLB),and Alzheimers disease(AD).
会议
Aging is associated with an increased risk for Parkinsons disease(PD)and dementia with Lewy bodies(DLB),in which alpha-synuclein(α-syn)oligomerization plays key pathogenic roles.
Objective Alzheimer disease(AD)is a fatal neurodegenerative disorder characterized by progressive cognitive impairment and memory loss.
Objectives: Optogenetics technology are able to conduct neuromodulation with high selectivity and high spatiotemporal resolution.
The systemic rotenone model of PD accurately replicates many aspects of the pathology of human PD.However,the major limitation of the rotenone model has been its variability in terms of the extend of
Parkinsons disease(PD)has become a social problem in China,seriously affecting population health and life quality and inhibiting economic development.
Objective Alzheimers disease(AD)is the most common type of dementia,which seriously affects the life quality of the elderly,but no effective treatment is found up to now.
Non-motor symptoms are of vital importance in Parkinsons disease(PD)in recent years,among which cardiovascular dysfunctions are commonly seen in PD patients before their motor signs.
Mutations in the ATP13A2 gene(PARK9)cause autosomal recessive,juvenile-onset Kufor-Rakeb syndrome(KRS),a neurodegenerative disease characterized by parkinsonism.